Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.


Journal

American journal of physiology. Endocrinology and metabolism
ISSN: 1522-1555
Titre abrégé: Am J Physiol Endocrinol Metab
Pays: United States
ID NLM: 100901226

Informations de publication

Date de publication:
01 11 2020
Historique:
pubmed: 15 9 2020
medline: 29 12 2020
entrez: 14 9 2020
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic linked to metabolic disease. The first stage of NAFLD is characterized by lipid accumulation in hepatocytes, but this can progress into nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). Western diets, high in fats, sugars, and cholesterol, are linked to NAFLD development. Murine models are often used to study NAFLD; however, there remains debate on which diet-induced model best mimics both human disease progression and pathogenesis. In this study, we performed a side-by-side comparison of two popular diet models of murine NAFLD/NASH and associated HCC, a high-fat diet supplemented with 30% fructose water (HFHF) and a Western diet high in cholesterol (WDHC), and these were compared with a common grain-based chow diet (GBD). Mice on both experimental diets developed liver steatosis, and WDHC-fed mice had greater levels of hepatic inflammation and fibrosis than HFHF-fed mice. In contrast, HFHF-fed mice were more obese and developed more severe metabolic syndrome, with less pronounced liver disease. Despite these differences, WDHC-fed and HFHF-fed mice had similar tumor burdens in a model of diet-potentiated liver cancer. Response to diet and resulting phenotypes were generally similar between sexes, albeit delayed in females. This study shows that modest differences in diet can significantly uncouple glucose homeostasis and liver damage. In conclusion, long-term feeding of either HFHF or WDHC is a reliable method to induce NASH and diet-potentiated liver cancer in mice of both sexes; however, the choice of diet involves a trade-off between severity of metabolic syndrome and liver damage.

Identifiants

pubmed: 32924526
doi: 10.1152/ajpendo.00321.2020
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

E863-E876

Auteurs

Hannah Zhang (H)

Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.

Mélissa Léveillé (M)

Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
Department of Medicine, University of Montreal, Montreal, Quebec, Canada.

Emilie Courty (E)

Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.

Aysim Gunes (A)

Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.

Bich N Nguyen (B)

Department of Pathology and Cell Biology, University of Montreal, Montreal, Quebec, Canada.
University of Montreal Health Network (CHUM), Montreal, Quebec Canada.

Jennifer L Estall (JL)

Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.
Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH